Suchergebnisse - "Grisanti, Salvatore"

PubPharm (16)

1

Advances in adrenocortical carcinoma pharmacotherapy : what is the current state of the art?

enthalten in: Expert opinion on pharmacotherapy | 2022

von Cremaschi, V. | Abate, A. | Cosentini, D. | +7

2

Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients : a prospective single-center clinical study

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2022

von Pedersini, R. | Zamparini, M. | Bosio, S. | +10

3

Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells

enthalten in: Endocrinology | 2022

von Abate, A. | Rossini, E. | Tamburello, M. | +11

4

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

5

Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy

enthalten in: Frontiers in endocrinology | 2021

von Grisanti, S. | Cosentini, D. | Laganà, M. | +8

6

Alternative treatment options for periorbital basal cell carcinoma

enthalten in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft | 2020

von Kakkassery, V. | Emmert, S. | Adamietz, I. | +7

7

In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆

enthalten in: Molecular and cellular endocrinology | 2019

von Fragni, M. | Palma Lopez, L. | Rossini, E. | +13

8

Antineoplastic activity of artemisinin in adrenocortical carcinoma

enthalten in: Endocrine | 2019

von Lorini, L. | Grisanti, S. | Ambrosini, R. | +6

9

Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients : Potential predictive role of treatment efficacy

enthalten in: PloS one | 2019

von Consoli, F. | Manganoni, A. | Grisanti, S. | +8

10

Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World : A Retrospective Study

enthalten in: Oncology | 2018

von Pedersini, R. | Vassalli, L. | Claps, M. | +7